HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Richard I. Whyte Michael S. Mulligan Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Whyte, R. I. Articles by Lynch, J. P. Search for Related Content PubMed PubMed Citation Articles by Whyte, R. I. Articles by Lynch, J. P., III

Ann Thorac Surg 1997;64:945-948
© 1997 The Society of Thoracic Surgeons

---

Original Article: General Thoracic

Mycophenolate Mofetil for Obliterative Bronchiolitis Syndrome After Lung Transplantation

Departments of Surgery and Medicine, University of Michigan, Ann Arbor, Michigan

Background. The development of obliterative bronchiolitis after lung transplantation portends a poor long-term outcome because of progressive decline in allograft function. There are currently no effective means of treating this condition.

Methods. Thirteen patients in whom obliterative bronchiolitis syndrome developed after lung transplantation were treated with mycophenolate mofetil, an antimetabolite immunosuppressant, at a dose of 1.5 g orally twice daily. Patients were followed up clinically and with pulmonary function testing.

Results. Duration of mycophenolate mofetil therapy ranged from 1 week to 24 months (mean duration, 11.4 months). Pulmonary function test results stabilized in the majority of patients with no significant further decline in forced expiratory volume in 1 second. Two patients died of progressive obliterative bronchiolitis, 1 patient is alive with progressive disease, and 1 patient died of an acute infection. The drug was discontinued in 2 additional patients. In no patient did severe leukopenia or cytomegalovirus infection develop; 1 patient had a fungal infection, and 7 patients experienced gastrointestinal side effects.

Conclusions. In the setting of obliterative bronchiolitis syndrome, mycophenolate mofetil is generally well tolerated and is associated with stabilization of pulmonary function test results. These findings suggest that the otherwise progressive process of obliterative bronchiolitis can be slowed.

This article has been cited by other articles:

				L. P. Nicod Mechanisms of airway obliteration after lung transplantation. Proceedings of the ATS, July 1, 2006; 3(5): 444 - 449. [Abstract] [Full Text] [PDF]

				C. Knoop, A. Haverich, and S. Fischer Immunosuppressive therapy after human lung transplantation Eur. Respir. J., January 1, 2004; 23(1): 159 - 171. [Abstract] [Full Text] [PDF]

				R. D. Davis Jr, C. L. Lau, S. Eubanks, R. H. Messier, D. Hadjiliadis, M. P. Steele, and S. M. Palmer Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 533 - 542. [Abstract] [Full Text] [PDF]

				J. W. K. van den BERG, A. GEERTSMA, W. van der BIJ, G. H. KOËTER, W. J. de BOER, D. S. POSTMA, and E. M. ten VERGERT Bronchiolitis Obliterans Syndrome after Lung Transplantation and Health-related Quality of Life Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1937 - 1941. [Abstract] [Full Text]

				S. M. Levine Can Bronchiolitis Obliterans Syndrome Be Diagnosed By Phone From the Comfort of Home? Chest, July 1, 1999; 116(1): 5 - 6. [Full Text] [PDF]

				C. B. Huddleston, E. N. Mendeloff, A. H. Cohen, S. C. Sweet, D. T. Balzer, and G. B. Mallory Jr Lung retransplantation in children Ann. Thorac. Surg., July 1, 1998; 66(1): 199 - 204. [Abstract] [Full Text] [PDF]